These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2545499)

  • 41. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
    Szczepański W
    Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selenoprotein P mRNA expression in human hepatic tissues.
    Li CL; Nan KJ; Tian T; Sui CG; Liu YF
    World J Gastroenterol; 2007 Apr; 13(16):2363-8. PubMed ID: 17511039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein.
    Ren YJ; Huang T; Yu HL; Zhang L; He QJ; Xiong ZF; Peng H
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):846-851. PubMed ID: 27924522
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunohistochemical ferritin in hepatocellular carcinoma.
    Cohen C; Berson SD; Shulman G; Budgeon LR
    Cancer; 1984 May; 53(9):1931-5. PubMed ID: 6322963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis.
    Wang W; Huang P; Wu P; Kong R; Xu J; Zhang L; Yang Q; Xie Q; Zhang L; Zhou X; Chen L; Xie H; Zhou L; Zheng S
    Oncotarget; 2015 Aug; 6(24):20252-65. PubMed ID: 25970780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development.
    Kang HJ; Chung DH; Sung CO; Yoo SH; Yu E; Kim N; Lee SH; Song JY; Kim CJ; Choi J
    Oncotarget; 2017 Apr; 8(16):27263-27276. PubMed ID: 28460481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of P53 and HSP70 in Chronic Hepatitis, Liver Cirrhosis, and Early and Advanced Hepatocellular Carcinoma Tissues and Their Diagnostic Value in Hepatocellular Carcinoma: An Immunohistochemical Study.
    Wang Z; Gou W; Liu M; Sang W; Chu H; Zhang W
    Med Sci Monit; 2015 Oct; 21():3209-15. PubMed ID: 26494212
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The expression of integrin beta 1 in normal hepatic tissues, hepatic cirrhosis tissues and hepatocellular carcinoma].
    Zhao G; Cui J; Qin Q; Li SS; Yin T; Chen LB; Wu HS; Wang CY
    Zhonghua Gan Zang Bing Za Zhi; 2010 May; 18(5):353-6. PubMed ID: 20510000
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Morphometric analysis of hepatocellular nodular lesions in HCV cirrhosis.
    Vertemati M; Moscheni C; Petrella D; Lamperti L; Cossa M; Gambacorta M; Goffredi M; Vizzotto L
    Pathol Res Pract; 2012 Apr; 208(4):240-4. PubMed ID: 22429827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term follow-up study of adenomatous hyperplasia in liver cirrhosis.
    Lencioni R; Caramella D; Bartolozzi C; Di Coscio G
    Ital J Gastroenterol; 1994 May; 26(4):163-8. PubMed ID: 7524802
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survivin overexpression in HCC and liver cirrhosis differentially correlates with p-STAT3 and E-cadherin.
    Peroukides S; Bravou V; Alexopoulos A; Varakis J; Kalofonos H; Papadaki H
    Histol Histopathol; 2010 Mar; 25(3):299-307. PubMed ID: 20054802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular evaluation of apoptotic versus antiapoptotic angiogenic markers in hepatocellular carcinoma.
    Abdel Aziz MT; El-Miligy D; Amin MA; El Ansari A; Ahmed HH; Marzouk S; Sabry D
    Clin Biochem; 2008 Aug; 41(12):1008-14. PubMed ID: 18339319
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alfentanil-induced miosis as a surrogate measure of alfentanil pharmacokinetics in patients with mild and moderate liver cirrhosis.
    Baririan N; Van Obbergh L; Desager JP; Verbeeck RK; Wallemacq P; Starkel P; Horsmans Y
    Clin Pharmacokinet; 2007; 46(3):261-70. PubMed ID: 17328584
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Difference in the in vitro uptake of bromodeoxyuridine between liver cirrhosis with and without hepatocellular carcinoma.
    Tarao K; Shimizu A; Harada M; Kuni Y; Ito Y; Tamai S; Iimori K; Sugimasa Y; Takemiya S; Okamoto T
    Cancer; 1989 Jul; 64(1):104-9. PubMed ID: 2543491
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tissue zinc status and drug elimination in patients with chronic liver disease.
    Barry M; Keeling PW; Feely J
    Clin Sci (Lond); 1990 Jun; 78(6):547-9. PubMed ID: 2165886
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impaired clearance of phenacetin in hepatic cirrhosis and fibrosis.
    Qu ZQ; Li XD; Liu HL; He P; Zhang X; Wu MC
    Int J Clin Pharmacol Ther; 2007 Jan; 45(1):55-62. PubMed ID: 17256451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Antipyrine clearance as a measure of drug metabolism in patients with diabetes mellitus].
    Oltmanns D; Dennin DE; Pentz R; Siegers CP
    Z Gastroenterol; 1984 Oct; 22(10):598-601. PubMed ID: 6506825
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of micronuclei formation and nuclear anomalies in regenerative nodules of human cirrhotic livers and relationship to hepatocellular carcinoma.
    de Almeida TM; Leitão RC; Andrade JD; Beçak W; Carrilho FJ; Sonohara S
    Cancer Genet Cytogenet; 2004 Apr; 150(1):16-21. PubMed ID: 15041218
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?
    Stefano JT; de Oliveira CP; Corrêa-Giannella ML; Soares IC; Kubrusly MS; Bellodi-Privato M; de Mello ES; de Lima VM; Carrilho FJ; Alves VA
    Liver Int; 2011 Mar; 31(3):377-85. PubMed ID: 21108736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.